
01
Developing and diversifying respite structures
02
Consolidating rights and training for carers
03
Improving health monitoring for family carers
04
Quality labelling throughout the country for "single points of contact", the "Maisons pour l’Autonomie et l’Intégration des malades Alzheimer" (MAIA)
05
Establishing "coordinators" throughout the country
06
Reinforcing support at home, advocating services by trained staff
07
Improving support at home using new technologies
08
Preparing and implementing a system for giving the diagnosis and providing counselling
09
Experimenting new payment terms for health professionals
10
Creating an Alzheimer’s disease information card for each patient
11
Creating memory units in areas that are not covered
12
Creating "memory resource and research centres" in areas that are not covered
13
Reinforcing the very active memory units
14
Monitoring drug-related iatrogenic accidents
15
Improving correct use of drugs
16
Creating specific units for patients suffering from behavioural problems within EHPADs
17
Creating specialized units within health care rehabilitation and follow-up (SSR) departments for Alzheimer’s patients
18
Accommodation for young patients
19
Identifying a national reference centre for young Alzheimer’s patients
20
A specific career and skills development plan for Alzheimer’s disease
21
Creating a foundation for scientific cooperation to stimulate and coordinate scientific research
22
Developing clinical research of Alzheimer’s disease and improving evaluation of non-drug therapies
23
Doctoral and post-doctoral grants
24
New assistant surgeon and hospital teaching assistant positions
25
Research in human and social sciences
26
Support for research groups working on innovative approaches
27
Support for methodological research groups in human and social sciences
28
Creation of a body of research in automatic image processing
29
Studying large patient populations (cohorts) with long-term monitoring
30
High-speed genotyping
31
Exploiting the genome sequencing of the microcebe
32
Training in clinical epidemiology
33
Developing links between public research and industry
34
Setting up epidemiological surveillance and follow up
35
Setting up a telephone helpline and a website for information and local advice
36
Holding regional conferences to support the implementation of the plan
37
Studying disease knowledge and attitudes
38
Creating a space for ethical thought about Alzheimer’s disease
39
Launching a discussion about the legal status of Alzheimer’s patients in institutions
40
Organising regular meetings focusing on the autonomy of people suffering from Alzheimer’s disease
41
Informing patients and their families about trials implemented in France
42
Making the fight against Alzheimer’s disease a priority for the European Union during the French presidency
43
Publicizing and promoting research across Europe
44
Holding a European conference in autumn 2008
45
Studying opinion and attitude about Alzheimer’s disease and the impact of the plan among patients and carers
The objective is to end the legal confusion relating to the difficulty of acquiring the consent of a person suffering from Alzheimer’s disease and to clarify the roles of the various people around the patient: trusted person, guardian, carer.
As early as 2004, the consensus group on freedom of movement described with precision the context in which a dependent person finds himself or herself cared for and on occasion accommodated against his or her will. Indeed, the impossibility of obtaining informed consent makes his or her agreement debatable even when it is expressed.
Moreover, in the patient’s own interests, caring for the patient may involve using techniques that seriously restrict his or her freedom (closed units, magnetic bracelets, restraint belts). Without questioning medical protocol and the reality of these methods being indicated, it must be admitted that the consequent deprivation of liberty must be legally supervised. This question is well known in the field of psychiatry. But the legal provisions in force in this area do not apply to medico-social establishments. The result is a legal vacuum that needs to be filled.
In addition, the law of 5 March 2007 reforming legal protection for adults now provides the possibility of organising one’s own protection in advance: anyone can now draw up a future protection mandate, entrusting responsibility for looking after them and their affairs when they can no longer do it themselves to a person of their choice. The appointed person may be given the role of legal representative or trusted person. This is a kind of living will that enables one’s own dependence to be anticipated. However, this legal tool cannot be applied to people who are already affected by Alzheimer’s disease.
Finally, while the new provisions of the 5 March 2007 law respond to situations of accommodation against the patient’s will or without their consent, including elderly people directed into medical retirement homes, by requiring a decision from a guardianship judge (juge des tutelles), these texts only apply to people subject to judicial or legal protection. No provisions exist outside these procedures.
Given the complexity of the issue, a working group has been set up to look at the subject: it consists of representatives of the ministries concerned and representation from the CCNE, the Alzheimer’s Collective and patients’ families.
Before 30 June, the group will propose concrete solutions for settling this delicate question, which raises the issue of fundamental freedoms and the rights of the most vulnerable citizens.
Lead supervision : Ministry of Social Affairs
Partner : Médéric Alzheimer